SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1352458509102372v1
15/5/547    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Fainardi, E
Right arrow Articles by Bellini, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fainardi, E
Right arrow Articles by Bellini, T
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

research-article

Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis

E Fainardi

Neuroradiology Unit, Department of Neurosciences and Rehabilitation, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, Corso della Giovecca 203, Ferrara I-44100, Italy henryfai{at}tin.it

M Castellazzi

Section of Neurology, Department of Medical and Surgical Sciences of the Communication and Behaviour, University of Ferrara, Arcispedale S. Anna, Corso della Giovecca 203, Ferrara I-44100, Italy

C Tamborino

Section of Neurology, Department of Medical and Surgical Sciences of the Communication and Behaviour, University of Ferrara, Arcispedale S. Anna, Corso della Giovecca 203, Ferrara I-44100, Italy

A Trentini

Section of Biochemistry and Clinical Biochemistry, Department of Biochemistry and Molecular Biology, University of Ferrara, via Luigi Borsari 46, Ferrara I-44100, Italy

MC Manfrinato

Section of Biochemistry and Clinical Biochemistry, Department of Biochemistry and Molecular Biology, University of Ferrara, via Luigi Borsari 46, Ferrara I-44100, Italy

E Baldi

Neurology Unit, Department of Neurosciences and Rehabilitation, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, Corso della Giovecca 203, Ferrara I-44100, Italy

MR Tola

Neurology Unit, Department of Neurosciences and Rehabilitation, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, Corso della Giovecca 203, Ferrara I-44100, Italy

F Dallocchio

Section of Biochemistry and Clinical Biochemistry, Department of Biochemistry and Molecular Biology, University of Ferrara, via Luigi Borsari 46, Ferrara I-44100, Italy

E Granieri

Neuroradiology Unit, Department of Neurosciences and Rehabilitation, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, Corso della Giovecca 203, Ferrara I-44100, Italy

T Bellini

Section of Biochemistry and Clinical Biochemistry, Department of Biochemistry and Molecular Biology, University of Ferrara, via Luigi Borsari 46, Ferrara I-44100, Italy

Background

Little is known about the involvement of matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor TIMP-2 in multiple sclerosis (MS).

Objective

To elucidate the actual implication of MMP-2 and TIMP-2 in MS.

Methods

Cerebrospinal fluid (CSF) and serum levels of active MMP-2 and TIMP-2 were measured by activity assay system and ELISA, respectively, in 67 patients with relapsing–remitting MS (RRMS), categorized according clinical and magnetic resonance imaging (MRI), and in 129 controls.

Results

Cerebrospinal fluid and serum active MMP-2/TIMP-2 ratio mean values and an intrathecal active MMP-2 production were more increased in RRMS than in non-inflammatory conditions (P < 0.001, P < 0.05, and P < 0.0001, respectively) and in MRI inactive than in MRI active RRMS (P < 0.02, P < 0.01 and P < 0.001, respectively). An intrathecal synthesis of active MMP-2 was more frequent in RRMS than in inflammatory disorders (P < 0.01). Serum active MMP-2/TIMP-2 ratio and MS disease duration were positively correlated (P < 0.02).

Conclusion

These findings suggest a potential role for MMP-2 activity in the termination of MS neuroinflammation related to remission of the disease and seem to indicate that serum MMP-2/TIMP-2 ratio may represent a useful biomarker for monitoring MS recovery phase.

Key Words: cerebrospinal fluid • intrathecal synthesis • MMP-2 • multiple sclerosis • TIMP-2

This version was published on May 1, 2009

Multiple Sclerosis, Vol. 15, No. 5, 547-554 (2009)
DOI: 10.1177/1352458509102372


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement